United Medical Laboratories, INC.

United Medical Laboratories, INC. was paid $53K by Medicaid between Jan 2018 and Jan 2022, across 18 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 42% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Virginia

Rank by total paid#38 of 78

Median peer was paid$37K

This provider vs. median1.4×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	1,773	$22K
2019	50	$69.04
2020	32	$1K
2021	1,348	$28K
2022	92	$1K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	42%	529	437	$22K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	12%	186	177	$6K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	11%	173	165	$6K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	9.5%	494	405	$5K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	7.0%	449	358	$4K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	2.9%	249	239	$2K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	2.9%	50	49	$2K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	2.7%	59	59	$1K
87340		2.3%	116	111	$1K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	2.3%	40	40	$1K
86762		1.8%	101	98	$951.56
87086	Culture, bacterial; quantitative colony count, urine	1.7%	121	116	$891.88

6 more codes

84702		1.4%	86	$757.51
86592		<1%	118	$451.61
36415	Collection of venous blood by venipuncture	<1%	440	$190.52
87070		<1%	26	$176.36
81003		<1%	44	$104.20
99001		0%	14	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCHANG, GEORGE (DIRECTOR)